• Amgen granted director Michael V. Drake 114 shares of common stock on Nov. 6, 2026.
• His direct beneficial ownership totaled 6,030 shares following the award.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amgen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000318154-26-000160), on November 09, 2026, and is solely responsible for the information contained therein.